BDBM299161 (6S,8R)-6-(3-fluoro-5-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)pyridin-2-yl)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline::US10125135, Example 50

SMILES C[C@@H]1Cc2c(ccc3[nH]ncc23)[C@@H](c2ncc(OCCN3CC(CF)C3)cc2F)N1CC(F)(F)F

InChI Key InChIKey=FWGZWHLTNCAOMT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299161   

TargetEstrogen receptor(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 299161BDBM299161(US10125135, Example 50 | (6S,8R)-6-(3-fluoro-5-(2-...)
Affinity DataIC50: 2.10nMAssay Description:The ability of compounds to bind to isolated Estrogen Receptor Alpha Ligand binding domain (ER alpha LBD (GST)) was assessed in competition assays us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent